For Medical Professionals

Industry News

Cell type responsible for scarring, skin-cancer growth identified by Stanford scientists
4/21/2015

A skin cell responsible for scarring, and a molecule that inhibits the cell's activity, have been identified by researchers at the Stanford University School of Medicine.

Angiogenesis inhibitors undermined by immune cells, says study
4/21/2015

Angiogenesis inhibitors--a widely used class of cancer drugs designed to shrink tumors by preventing them from forming new blood vessels--often work in the short term, but usually become...

Breast cancer website launched to provide info on dense breasts
4/21/2015

Recognizing that both women and their doctors are often confused after a mammogram reveals the woman has dense breasts, a nonprofit organization has launched a major new educational website.

DNA blood test detects lung cancer mutations
4/21/2015

Circulating tumor DNA in blood a valid option for EGFR testing in patients who do not have accessible tumor tissue, study showsCancer DNA circulating in the bloodstream of lung cancer patients...

Annals of Internal Medicine goes Beyond the Guidelines to discuss real-world application of lung cancer screening recommendations
4/20/2015

New multicomponent educational program features challenging clinical cases from Beth Israel Deaconess Medical Center Grand Rounds Sessions.See patient video at www.annals.

Evidence points to fallopian-tube origins of ovarian cancers
4/20/2015

A new surgical approach that removes the fallopian tubes while sparing the ovaries may provide premenopausal women at high risk for ovarian cancer, particularly those with BRCA1/2 mutations, with a...

New assay helps determine lymphoma subtypes simply, quickly, and inexpensively
4/20/2015

With the advent of targeted lymphoma therapies on the horizon, it becomes increasingly important to differentiate the two major subtypes of diffuse large B-cell lymphoma (DLBCL), which is the most...

One in four advanced lung cancer patients tested for EGFR mutations started on first-line treatment before test results available
4/20/2015

Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung...

Similarities between polycystic kidney disease, cancer may point to future therapeutic options
4/20/2015

Researchers at Fox Chase Cancer Center recently conducted a review of the pathological features of a progressive inherited disease called autosomal dominant polycystic kidney disease (ADPKD).

Genomic profiling of gastric cancer identifies drug-targetable mutations
4/20/2015

The majority of gastric cancers harbor genomic alterations (GAs) associated with potential benefit from targeted therapies, according to a new study published in The Oncologist.